TipRanks
Go Ultimate55% OFF

Xinyang Maojian Group (0362) AI Stock Analysis

Top Page

HK:0362

Xinyang Maojian Group

(HKEX:0362)

Select Model
Rating:43Neutral
Price Target:HKD 0.01â–¼(-6.67% Downside)
Action:initiatedcoverage
Date:07/25/25

The overall stock score of 43 reflects significant concerns, primarily driven by extremely weak financial performance with declining revenue, persistent losses, negative equity, and high debt. Technical analysis indicates a long-term downtrend despite oversold conditions, and valuation remains uncertain due to negative earnings. Financial health is the most critical factor dragging down the score.

Positive Factors
Market PositionThe company's specialization in Xinyang Maojian tea, a renowned variety, positions it well in the niche market for high-quality tea, potentially attracting loyal consumers and differentiating it from competitors.
Negative Factors
Revenue DeclineA consistent decline in revenue indicates challenges in maintaining market share and competitiveness, which can impact long-term growth prospects and financial health.

Xinyang Maojian Group (0362) vs. iShares MSCI Hong Kong ETF (EWH)

-2%0%3%5%8%10%13%15%18%HK:03620.00%EWH+7.37%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
HKD 20.27M
Dividend Yield
―
Average Volume (3M)
―
Price to Earnings (P/E)
-0.1
Beta (1Y)
0.11
Revenue Growth
―
EPS Growth
―
Country
Hong Kong
Employees
115
Sector
Utilities
Sector Strength
66
Industry
Regulated Electric

Xinyang Maojian Group Business Overview & Revenue Model

Company Description

China Zenith Chemical Group Limited functions as an investment holding entity, primarily engaged in the generation and distribution of heat and power across the People's Republic of China. The company's operations are divided into three core segments...

How the Company Makes Money

Xinyang Maojian Group generates revenue through the sale of its tea products, which include both loose leaf and packaged tea varieties. The company leverages its extensive supply chain and distribution network to reach a wide range of customers, from...

Xinyang Maojian Group Financial Statement Overview

Summary

Financial performance is critically weak with a drastic revenue decline of 68.7% to 31.6M in 2024, persistent net losses (net profit margin of -514.9%), negative equity (-1.01B), and high debt (1.17B). While there are minor improvements in gross margin and cash flow outflows, the overall financial health indicates severe operational and structural challenges.

Income Statement

15Very Negative

Balance Sheet

10Very Negative

Cash Flow

20Very Negative
Financial statement breakdown
BreakdownTTMJun 2023Jun 2022Jun 2021Jun 2020Jun 2020
Income Statement
Total Revenue28.35M31.56M100.85M198.66M194.34M229.02M
Gross Profit-12.81M11.15M-5.10M32.48M-61.06M-25.57M
EBITDA-31.45M-39.20M-9.27M-30.19M-175.57M-162.54M
Net Income-144.45M-162.50M-155.88M-1.06B-354.89M-450.35M
Balance Sheet
Total Assets380.92M478.10M666.63M1.24B1.93B2.07B
Cash, Cash Equivalents and Short-Term Investments1.19M30.76M3.01M14.85M8.82M47.34M
Total Debt1.12B1.17B1.17B1.26B1.13B1.26B
Total Liabilities1.46B1.49B1.61B2.06B1.57B1.98B
Stockholders Equity-1.08B-1.01B-955.36M-873.17M302.56M29.56M
Cash Flow
Free Cash Flow-18.44M-8.02M-20.77M-69.92M-16.58M-76.85M
Operating Cash Flow-17.26M-5.25M-12.76M-26.69M3.08M-58.09M
Investing Cash Flow74.23M642.00K-8.42M-34.15M-26.09M-27.64M
Financing Cash Flow-56.67M32.44M9.59M26.09M23.98M126.99M

Xinyang Maojian Group Technical Analysis

Technical Analysis SentimentNegative
Last Price0.01

Price Trends

50DMA0.02Negative
100DMA0.02Negative
200DMA0.02Negative

Market Momentum

MACD-0.00Neutral
STOCH100.00Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0362, the sentiment is Negative. The current price of 0.01 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.02, indicating a bearish trend. The MACD of -0.00 indicates Neutral momentum. The RSI at is Neutral, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0362.

Xinyang Maojian Group Peers Comparison

Overall Rating

UnderperformOutperform
Sector (66)

Financial Indicators

HK:0362 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *66Neutral$17.65B18.105.60%3.62%6.62%11.55%
HK:0681HK:068158NeutralHKD 241.23M-1.16-7.54%―-8.96%-597.67%
HK:1026HK:102650NeutralHKD 461.61M-2.89-30.39%―4.98%-49.74%
HK:0362HK:036243NeutralHKD 20.27M-0.0716.55%―――
HK:8631HK:863118UnderperformHKD 20.64M-5.1630.27%―――

* Utilities Sector Average

Performance Comparison

-50%0%50%HK:0362HK:1026HK:0681HK:8631HK:2481HK:2655Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
HK:0362 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
HK:0362Xinyang Maojian Group 0.010.000.00%
HK:1026Universal Technologies Holdings Limited0.08-0.02-20.00%
HK:0681Chinese People Holdings Co. Ltd.0.03-0.00-10.00%
HK:8631Sun Kong Holdings Ltd.0.43-0.05-10.42%
HK:2481Wise Living Technology Co., Ltd Class H2.460.135.67%
HK:2655Guoxia Technology Co., Ltd. Class H10.08-33.72-76.99%

Xinyang Maojian Group Corporate Events

China Zenith Chemical Faces Continued Suspension and Delisting Risk as Liquidators Review Operations

Dec 22, 2025

China Zenith Chemical Group Limited, a Hong Kong-listed chemical manufacturer now in compulsory liquidation, is under the control of joint and several liquidators who are still assessing the state of its business by examining available books and reco...

China Zenith Chemical Group Appoints Liquidators Amidst Operational Changes

Nov 21, 2025

China Zenith Chemical Group Limited, currently in compulsory liquidation, has appointed Osman Mohammed Arab and Lai Wing Lun as joint and several liquidators following a High Court order. The company has also announced a change in its principal place...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Jul 25, 2025